Teva sues FDA over bid to block approval of generic Copaxone
Teva sues FDA over bid to block approval of generic Copaxone
Re: Teva sues FDA over bid to block approval of generic Copa
Teva Pharmaceutical Industries Ltd. lost a bid to block approval of a generic form of Copaxone, a multiple sclerosis drug that may account for half the company’s profit, 10 days before the patent on the medication expires........... Read More - http://www.ms-uk.org/copaxone
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1296 Views
-
Last post by nellie
Fri Oct 12, 2018 8:02 am
-
- 0 Replies
- 920 Views
-
Last post by MSUK
Wed Feb 14, 2018 6:11 am
-
-
Roche's New MS Drug Set For Early FDA Approval
by seeva » Sun Jan 28, 2018 4:45 am » in Drug Pipeline - 2 Replies
- 2420 Views
-
Last post by NHE
Fri Feb 02, 2018 9:27 pm
-
-
-
Pipeline as of 2019 with expected approval dates
by frodo » Fri Dec 21, 2018 6:16 am » in Drug Pipeline - 0 Replies
- 851 Views
-
Last post by frodo
Fri Dec 21, 2018 6:16 am
-
-
-
Higher dose of MS drug Glatopa finally gets US approval
by MSUK » Wed Feb 14, 2018 6:13 am » in General Discussion - 0 Replies
- 901 Views
-
Last post by MSUK
Wed Feb 14, 2018 6:13 am
-
-
-
Response to Copaxone can be predicted
by frodo » Thu Nov 07, 2019 7:11 am » in Chronic Cerebrospinal Venous Insufficiency (CCSVI) - 0 Replies
- 86 Views
-
Last post by frodo
Thu Nov 07, 2019 7:11 am
-
-
- 0 Replies
- 576 Views
-
Last post by frodo
Thu May 16, 2019 8:09 am